Ayşegül ATEŞ DEĞİRMENCİ
Eczacılık Fakültesi, Temel Eczacılık Bölümü, Farmasötik Mikrobiyoloji Anabilim Dalı
Research areas: Health Sciences, Pharmacology and Therapeutics, Pharmaceutical Microbiology, Microbiology, Basic Pharmaceutics Sciences, Professional Sciences, Pharmaceutical Chemistry, Life Sciences, Natural Sciences, Biotechnology
Publications
- Empagliflozin modulates biofilm formation and virulence-associated gene expression in multidrug-resistant Staphylococcus aureus and Acinetobacter baumannii (2026)
- Farklı pH Ortamlarında Çinko İçerikli ve Geleneksel Cam İyonomer Simanların İyon Salımı ve Antibakteriyel Etkinliklerinin Karşılaştırılması: İn Vitro Çalışma (2026)
- Targeting biofilm-related genes in a clinical methicillin-resistant Staphylococcus aureus isolate using CRISPR-Cas9 gene editing (2026)
- Effects of empagliflozin and metformin on biofilm formation and pathogenicity factors of urinary Escherichia coli isolates (2026)
- Lipoplex as a useful tool for resensitization of methicillin-resistant Staphylococcus aureus to erythromycin via CRISPR-Cas technology (2026)
- Lipoplex as a useful tool for resensitization of Methicillin-Resistant Staphylococcus aureus to Erythromycin via CRISPR-Cas technology (2026)
- THE EFFECT OF INCUBATION TEMPERATURE ON BIOFILM CAPACITY IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS, ACINETOBACTER BAUMANNII, AND STENOTROPHOMONAS MALTOPHILIA ISOLATES (2025)
- Antibacterial activity and cytocompatibility evaluation of cefpodoxime proxetil loaded eudragit rs 100 nanoparticles (2024)
- Precision Genome Editing Unveils a Breakthrough in Reversing Antibiotic Resistance: CRISPR/Cas9 Targeting of Multi-Drug Resistance Genes in Methicillin-Resistant Staphylococcus aureus (2024)
- An innovative approach to biofilm-associated infections: CRISPR/Cas9-Mediated Genetic Intervention (2024)
- STAPHYLOCOCCUS AUREUS KAYNAKLI İMPETİGO TEDAVİSİNDE BERBERİN YÜKLÜ NANOEMÜLSİYON JEL FORMÜLASYONU VE MİKROBİYOLOJİK DEĞERLENDİRİLMESİ (2024)
- SELEKOKSİB İÇEREN JEL FORMÜLASYONU GELİŞTİRİLMESİ VE STREPTOCOCCUS MUTANS'A KARŞI ANTİMİKROBİYAL VE ANTİBİYOFİLM ÖZELLİĞİNİN İNCELENMESİ (2024)
- Yeni Bir Antimikrobiyal Olan Lefamulinin Klinik Streptococcus pneumoniae Ve Metisilin Dirençli Stapylococcus aureus İzolatları Üzerine Etkinliğinin İncelenmesi (2024)
- THE STRUGGLE FOR SURVIVAL: PHAGE-BACTERIA ARMS RACE (2024)
- CRISPR-Cas9-Mediated Targeting of Multidrug Resistance Genes in Methicillin-Resistant Staphylococcus aureus (2024)
- Design of Azithromycin Loaded Eudragit RL 100 Nanoparticles with Extended Antibacterial Effect (2023)
- Bacterial Circadian Rhythm (2023)
- COVID-19 ve Tanı Yöntemleri (2023)
- Antimicrobial Activity Evaluation of Newly Synthesized N,N-Disubstituted Taurinamidobenzenesulfonamide Derivatives (2021)
- Antimicrobial activity of 4-Substituted-N-(2-(N-(4-sulfamoylphenyl)sulfamoyl)ethyl)benzamidederivatives (2021)
- Antimicrobial activity screening of a series of taurine derivatives (2021)
- COVID-19 Pandemisinde Mikrobiyolojik Tanı Yöntemleri (2021)
- Antimicrobial Activity Evaluation of Newly Synthesized N,N-Disubstituted Taurinamidobenzenesulfonamide Derivatives (2021)
- Alternative Therapies to Antibiotics: CRISPR-Cas antimicrobials (2020)
- Antifungal and antibiofilm activities of selective serotonin reuptake inhibitors alone and in combination with fluconazole (2020)
- IN VITRO ANTIMICROBIAL AND ANTIBIOFILM EFFECTS OF THYMOL AGAINST CLINICAL METHICILLIN RESISTANT STAPHYLOCOCCUSAUREUS ISOLATES (2018)
- Investigation Of The Efficacy Of Some Plant Extracts And Phenolic Essential Oil Components On Uropathogenic Escherichia Coli Isolates (2018)
- ANTIBIOFILM ACTIVITIES OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AGAINST CLINICAL CANDIDA ISOLATES (2018)
- Üropatojenik Escherichia coli kökenleriüzerine bazı bitki ekstreleri ve fenolik uçucu yağ bileşenlerinin etkinliğinin araştırılması (2018)
- Antifungal Activities Of Selective Seratonin Reuptake Inhibitors (ssris) Alone And In Combination With Fluconazole (2017)